The price of Relay Therapeutics Inc (NASDAQ: RLAY) closed at $7.53 in the last session, down -3.34% from day before closing price of $7.79. In other words, the price has decreased by -$0.26 from its previous closing price. On the day, 1108836 shares were traded. RLAY stock price reached its highest trading level at $8.01 during the session, while it also had its lowest trading level at $7.50.
Ratios:
We take a closer look at RLAY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 25.44 and its Current Ratio is at 25.44. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 19, 2023, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $29.
On April 13, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on April 13, 2023, with a $29 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 29 ’24 when Bergstrom Donald A sold 3,178 shares for $9.64 per share. The transaction valued at 30,636 led to the insider holds 530,878 shares of the business.
Catinazzo Thomas sold 2,005 shares of RLAY for $19,328 on Jan 29 ’24. The Chief Financial Officer now owns 341,846 shares after completing the transaction at $9.64 per share. On Jan 29 ’24, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 1,929 shares for $9.64 each. As a result, the insider received 18,596 and left with 327,738 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1.02B and an Enterprise Value of 326.58M. For the stock, the TTM Price-to-Sale (P/S) ratio is 38.66 while its Price-to-Book (P/B) ratio in mrq is 1.28. Its current Enterprise Value per Revenue stands at 12.78 whereas that against EBITDA is -0.87.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $19.23, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 9.55, while the 200-Day Moving Average is calculated to be 9.87.
Shares Statistics:
According to the various share statistics, RLAY traded on average about 1.07M shares per day over the past 3-months and 1.5M shares per day over the past 10 days. A total of 127.46M shares are outstanding, with a floating share count of 92.20M. Insiders hold about 29.71% of the company’s shares, while institutions hold 71.66% stake in the company. Shares short for RLAY as of Feb 29, 2024 were 11M with a Short Ratio of 10.29, compared to 9.45M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.38% and a Short% of Float of 10.79%.
Earnings Estimates
The company has 9 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.7 for the current quarter, with a high estimate of -$0.63 and a low estimate of -$0.81, while EPS last year was -$0.78. The consensus estimate for the next quarter is -$0.73, with high estimates of -$0.64 and low estimates of -$0.86.
Analysts are recommending an EPS of between -$2.44 and -$3.33 for the fiscal current year, implying an average EPS of -$2.92. EPS for the following year is -$2.78, with 9 analysts recommending between -$2.31 and -$3.11.
